Tactile Systems Technology, Inc.
$25.52
▼
-5.28%
2026-04-21 09:45:00
tactilemedical.com
NGM: TCMD
Explore Tactile Systems Technology, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$580.59 M
Current Price
$25.52
52W High / Low
$37.77 / $8.61
Stock P/E
30.42
Book Value
$9.76
Dividend Yield
—
ROCE
12.57%
ROE
8.77%
Face Value
—
EPS
$0.82
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
1,086
Beta
0.99
Debt / Equity
7.29
Current Ratio
4.03
Quick Ratio
3.69
Forward P/E
15.83
Price / Sales
1.62
Enterprise Value
$458.26 M
EV / EBITDA
12.76
EV / Revenue
1.39
Rating
None
Target Price
$38
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Penumbra, Inc. | $333.46 | 73.7 | $13.1 B | — | 11.52% | 13.78% | $362.41 / $221.26 | $36.39 |
| 2. | Cytosorbents Corporation | $0.65 | — | $41.24 M | — | -41.3% | -96.39% | $1.39 / $0.5 | $0.09 |
| 3. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 4. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 5. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 6. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 7. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 103.59 M | 85.75 M | 78.91 M | 61.27 M | 85.58 M | — |
| Operating Profit | 18.77 M | 10.96 M | 4.08 M | -4.54 M | 12.52 M | — |
| Net Profit | 10.63 M | 8.21 M | 3.22 M | -2.97 M | 9.72 M | — |
| EPS in Rs | 0.47 | 0.36 | 0.14 | -0.13 | 0.43 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 329.52 M | 292.98 M | 274.42 M | 246.78 M |
| Operating Profit | 29.28 M | 22.18 M | 18.04 M | -12.76 M |
| Net Profit | 19.09 M | 16.96 M | 28.52 M | -17.87 M |
| EPS in Rs | 0.84 | 0.75 | 1.25 | -0.79 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 273.94 M | 297.92 M | 281.44 M | 255 M |
| Total Liabilities | 55.04 M | 81.33 M | 87.8 M | 133.6 M |
| Equity | 218.9 M | 216.6 M | 193.64 M | 121.4 M |
| Current Assets | 165.17 M | 177.56 M | 145.29 M | 119.76 M |
| Current Liabilities | 40.96 M | 40.7 M | 41.06 M | 64.33 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 42.81 M | 40.66 M | 35.85 M | 5.21 M |
| Investing CF | -2.54 M | -2.5 M | -2.48 M | -1.91 M |
| Financing CF | -51.2 M | -4.82 M | 5.73 M | -9.6 M |
| Free CF | 40.28 M | 38.15 M | 33.37 M | 3.29 M |
| Capex | -2.54 M | -2.51 M | -2.48 M | -1.92 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 12.47% | 6.76% | 11.2% | — |
| Earnings Growth % | 12.54% | -40.52% | 259.6% | — |
| Profit Margin % | 5.79% | 5.79% | 10.39% | -7.24% |
| Operating Margin % | 8.89% | 7.57% | 6.57% | -5.17% |
| Gross Margin % | 75.91% | 73.96% | 71.11% | 71.31% |
| EBITDA Margin % | 11.84% | 11.05% | 9.64% | 0.71% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.